RAIsonance Releases Preliminary Results from AudibleHealth Dx Validation Study

GREENWOOD VILLAGE, Colo., Aug. 26, 2022 /PRNewswire/ — RAIsonance, Inc., a group of AI-powered technology solutions companies, today reported the preliminary results of its AudibleHealth Dx clinical validation study. The purpose of the trial was to evaluate the AudibleHealth Dx Software…

Click here to view original post